News

  • 22 January 2018

    Kite and Pfizer to assess combination therapy for lymphoma

    Gilead Sciences' subsidiary Kite has signed a clinical trial collaboration to evaluate its Yescarta (axicabtagene ciloleucel) in combination with Pfizer’s utomilumab for the treatment of refractory large B-cell lymphoma. 

  • 19 January 2018

    AI robot aids scientists in malaria discovery

    An artificially intelligent (AI) robot ‘scientist’ has assisted researchers at the University of Cambridge in finding a potential antimalarial drug from an ingredient commonly found in toothpaste.